Equity Overview
Price & Market Data
Price: $78.71
Daily Change: -$2.48 / 3.15%
Daily Range: $77.73 - $83.42
Market Cap: $4,151,708,416
Daily Volume: 1,734,776
Performance Metrics
1 Week: -8.97%
1 Month: -11.05%
3 Months: 5.42%
6 Months: 54.24%
1 Year: 73.79%
YTD: 75.11%
Company Details
Employees: 92
Sector: Health technology
Industry: Pharmaceuticals: major
Country:
Details
Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is Diazoxide Choline Extended-Release tablets, a once-daily oral tablet which is in Phase III clinical trials for the treatment of Prader-Willi Syndrome. The company was formerly known as Capnia, Inc. and changed its name to Soleno Therapeutics, Inc. in May 2017. Soleno Therapeutics, Inc. was incorporated in 1999 and is headquartered in Redwood City, California.